F-group (family)

2004.1.1.19 Ras

Ligands and drugs

5,072
Member domains
2,403
with ligand contacts (≤ 4 Å)
47.4% of members
2,039
with DrugDomain annotations
40.2% of members
1,994
with a DrugBank compound
39.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 2004.1.1.19 belongs to X-group 2004 P-loop domains-like, which binds 7.5 ligand superclasses per 20 proteins, narrower than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB04315GDPGuanosine-5'-Diphosphate825
DB02082GNPPhosphoaminophosphonic acid guanylate ester659
DB04137GTPGuanosine-5'-Triphosphate227
DB01864GSP5'-Guanosine-Diphosphate-Monothiophosphate78
DB03725GCP5'-Guanylylmethylenebisphosphonate63
DB03345BMEMercaptoethanol12
DB1857317F1,​2-​Dioleoyl-​sn-​glycero-​3-​phospho-​L-​serine8
DB04447DTT1,4-Dithiothreitol6
DB08751XY2N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE6
DB01692DTUDithioerythritol5
DB04444ALFTetrafluoroaluminate Ion5
DB00131AMPAdenosine phosphate4
DB03690PCW(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide4
DB02623GNHAminophosphonic acid-guanylate ester3
DB03434MPO3-(N-morpholino)propanesulfonic acid3
DB03435UDPUridine-5'-Diphosphate3
DB00145GLYGlycine2
DB00157NAINADH2
DB02210HEZHexane-1,6-Diol2
DB02693D1D(4S,5S)-1,2-dithiane-4,5-diol2

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION1,975
GDPGUANOSINE-5'-DIPHOSPHATE989
GNPPHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER787
GTPGUANOSINE-5'-TRIPHOSPHATE271
CAmetalCALCIUM ION153
GSP5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE80
CLCHLORIDE ION75
GCPPHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER73
NAmetalSODIUM ION45
AF3ALUMINUM FLUORIDE40
ZNI(1R,5S,6r)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl}-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide30
UNXUNKNOWN ATOM OR ION27
A1AHB(1R,2S)-N-[(1P,7S,9S,13R,20M)-21-ethyl-20-{2-[(1R)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide22
BEFBERYLLIUM TRIFLUORIDE ION20
ZNmetalZINC ION15
17FO-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine14
COmetalCOBALT (II) ION14
MGFTRIFLUOROMAGNESATE13
R6W(3~{S})-5-oxidanyl-3-[2-[[6-[[3-[(1~{S})-6-oxidanyl-3-oxidanylidene-1,2-dihydroisoindol-1-yl]-1~{H}-indol-2-yl]methylamino]hexylamino]methyl]-1~{H}-indol-3-yl]-2,3-dihydroisoindol-1-one13
BMEBETA-MERCAPTOETHANOL12